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Background 
Grampian has a relatively unique position of an integrated biochemistry service for the whole region. This is 
helpful when studying AKI, where accurate baseline is crucial and one missing test result can alter findings. E-
alert AKI systems that appear to perform reasonably in Grampian may not perform as well in other areas if 
care is shared across different services that are not integrated. 
Grampian biochemistry service contains two linked laboratories in Aberdeen and Elgin. Of 417295 patients 
with biochemistry profiles in Grampian 1999-2009, there were 32053 patients (7.7%) that had blood tests 
processed by each of the two laboratories (i.e. border patients). Without integration of the two laboratories, 
this minority of patients may be at risk of being misclassified by an automated detection algorithm. Note that 
in other areas the proportion of patients in border areas will vary greatly, but this analysis here has been 
restricted only to those 32053 bordering patients (integration will have made no difference in the others). 
Methods 
In this analysis the NHS England AKI detection algorithm was compared for each year from 2003-2008 between 
two set ups: 
1. Grampian biochemistry service as it functions in current practice (two linked laboratories providing an 
integrated service) 
2. If the Aberdeen and Elgin laboratories were no longer integrated (hypothetical) 
AKI identified in the current integrated service was regarded as “reference standard” for this study. The 32053 
patients in bordering areas with and without AKI blood tests were compared in 2x2 plots with sensitivity and 
false positive rates. 
Table 1 - Number of patients with AKI e-alerts in integrated (reference) and non-integrated services 
Integrated (reference standard) Not integrated     
2003  Neg. Pos. Total    
 “true” normal 30,933 34 30,967    
 “true” abnormal 147 939 1,086 sensitivity 86.5 (84.3-88.4) 
 Total 31,080 973 32,053 false positive 3.5 (2.4-4.8) 
2004  Neg. Pos. Total    
 “true” normal 30,854 46 30,900    
 “true” abnormal 180 973 1,153 sensitivity 84.4 (82.2-86.4) 
 Total 31,034 1,019 32,053 false positive 4.5 (3.3-6.0) 
2005  Neg. Pos. Total    
 “true” normal 30,781 47 30,828    
 “true” abnormal 145 1,080 1,225 sensitivity 88.2 (86.2-89.9) 
 Total 30,926 1,127 32,053 false positive 4.2 (3.1-5.5) 
2006  Neg. Pos. Total    
 “true” normal 30,465 56 30,521    
 “true” abnormal 215 1,317 1,532 sensitivity 86.0 (84.1-87.7) 
 Total 30,680 1,373 32,053 false positive 4.1 (3.1-5.3) 
2007  Neg. Pos. Total    
 “true” normal 30,598 55 30,653    
 “true” abnormal 222 1,178 1,400 sensitivity 84.1 (82.1-86.0) 
 Total 30,820 1,233 32,053 false positive 4.5 (3.4-5.8) 
2008  Neg. Pos. Total    
 “true” normal 30,594 79 30,673    
 “true” abnormal 187 1,193 1,380 sensitivity 86.4 (84.5-88.2) 
 Total 30,781 1,272 32,053 false positive 6.2 (4.9-7.7) 
Findings 
Approximately 10-15% of detectable AKI would be missed in patients in bordering areas if laboratories were 
not integrated. In addition ~5% of patients would be alerted as AKI who would not if more complete integrated 
data were available. 
Limitations 
This analysis uses the NHS England algorithm in an integrated service as reference standard, but even in this 
setting misclassification of patients can occur. These findings also only apply to those patients with blood tests 
processed in both laboratories. This is a minority of patients in Grampian and will vary in different regions. 
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